אטורבה - דקס 10 Izrael - hebrejščina - Ministry of Health

אטורבה - דקס 10

dexcel pharma technologies ltd - atorvastatin as calcium - טבליה - atorvastatin as calcium 10 mg - atorvastatin

אטורבה - דקס 20 Izrael - hebrejščina - Ministry of Health

אטורבה - דקס 20

dexcel pharma technologies ltd - atorvastatin as calcium - טבליה - atorvastatin as calcium 20 mg - atorvastatin

אטורבה - דקס 40 Izrael - hebrejščina - Ministry of Health

אטורבה - דקס 40

dexcel pharma technologies ltd - atorvastatin as calcium - טבליה - atorvastatin as calcium 40 mg - atorvastatin

סימבקסון 20 Izrael - hebrejščina - Ministry of Health

סימבקסון 20

dexcel pharma technologies ltd - simvastatin - קפליות - simvastatin 20 mg - simvastatin

סימבקסון 40 Izrael - hebrejščina - Ministry of Health

סימבקסון 40

dexcel pharma technologies ltd - simvastatin - קפליות - simvastatin 40 mg - simvastatin

סימבקסון 80 Izrael - hebrejščina - Ministry of Health

סימבקסון 80

dexcel pharma technologies ltd - simvastatin - קפליות - simvastatin 80 mg - simvastatin

קלופידקסל 75 Izrael - hebrejščina - Ministry of Health

קלופידקסל 75

dexcel pharma technologies ltd - clopidogrel as besylate 75 mg - film coated tablets - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows:• recent mi, recent stroke or established peripheral arterial disease: patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. for patients with a history of recent myocardial infarction (mi), recent stroke or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new mi (fatal or not) and other vascular death.• acute coronary syndrome: for patients with acute coronary syndrome (non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction), in combination with asa in medically treated patients eligible for thrombolytic therapy, and those who are to be managed with percutaneous coronary intervention (with or without stent) or cabg clopi

פראמול פלוס Izrael - hebrejščina - Ministry of Health

פראמול פלוס

dexcel ltd, israel - caffeine; paracetamol - קפליות - paracetamol 500 mg; caffeine 50 mg - paracetamol - paracetamol - relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.

קסמיאול Izrael - hebrejščina - Ministry of Health

קסמיאול

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ג'ל - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - betamethasone - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

לטרוזול דקסל Izrael - hebrejščina - Ministry of Health

לטרוזול דקסל

dexcel ltd, israel - letrozole - טבליות מצופות פילם - letrozole 2.5 mg - letrozole - letrozole - letrozole - dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. letrozole - dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.